Suppr超能文献

酰基辅酶A与肝脏脂肪酸结合蛋白的结合:对酰基辅酶A合成的影响。

Binding of acyl-CoA to liver fatty acid binding protein: effect on acyl-CoA synthesis.

作者信息

Burrier R E, Manson C R, Brecher P

出版信息

Biochim Biophys Acta. 1987 Jun 23;919(3):221-30. doi: 10.1016/0005-2760(87)90261-x.

Abstract

The ability of purified rat liver and heart fatty acid binding proteins to bind oleoyl-CoA and modulate acyl-CoA synthesis by microsomal membranes was investigated. Using binding assays employing either Lipidex 1000 or multilamellar liposomes to sequester unbound ligand, rat liver but not rat heart fatty acid binding protein was shown to bind radiolabeled acyl CoA. Binding studies suggest that liver fatty acid binding protein has a single binding site acyl-CoA which is separate from the two binding sites for fatty acids. Experiments were then performed to determine how binding may influence acyl-CoA metabolism by liver microsomes or heart sarcoplasmic reticulum. Using liposomes as fatty acid donors, liver fatty acid binding protein stimulated acyl-CoA production, whereas that from heart did not stimulate production over control values. 14C-labeled fatty acid-fatty acid binding protein complexes were prepared, incubated with membranes, and acyl-CoA synthetase activity was determined. Up to 70% of the fatty acid could be converted to acyl-CoA in the presence of liver fatty acid binding protein but in the presence of heart fatty acid binding protein, only 45% of the fatty acid was converted. Liver but not heart fatty acid binding protein bound the acyl-CoA formed and removed it from the membranes. The amount of product formed was not changed by additional membrane, enzyme cofactors, or incubation time. Additional liver fatty acid binding protein was the only factor found that stimulated product formation. Acyl-CoA hydrolase activity was also shown in the absence of ATP and CoA. These studies suggest that liver fatty acid binding protein can increase the amount of acyl-CoA by binding this ligand, thereby removing it from the membrane and possibly aiding transport within the cell.

摘要

研究了纯化的大鼠肝脏和心脏脂肪酸结合蛋白结合油酰辅酶A以及调节微粒体膜酰基辅酶A合成的能力。使用采用Lipidex 1000或多层脂质体来隔离未结合配体的结合测定法,结果显示大鼠肝脏而非大鼠心脏脂肪酸结合蛋白能够结合放射性标记的酰基辅酶A。结合研究表明,肝脏脂肪酸结合蛋白具有一个酰基辅酶A结合位点,该位点与两个脂肪酸结合位点不同。随后进行实验以确定这种结合如何影响肝脏微粒体或心脏肌浆网的酰基辅酶A代谢。使用脂质体作为脂肪酸供体,肝脏脂肪酸结合蛋白刺激了酰基辅酶A的产生,而心脏脂肪酸结合蛋白则未使产量超过对照值。制备了14C标记的脂肪酸 - 脂肪酸结合蛋白复合物,与膜一起孵育,并测定酰基辅酶A合成酶活性。在存在肝脏脂肪酸结合蛋白的情况下,高达70%的脂肪酸可转化为酰基辅酶A,但在存在心脏脂肪酸结合蛋白的情况下,只有45%的脂肪酸被转化。肝脏而非心脏脂肪酸结合蛋白结合形成的酰基辅酶A并将其从膜中去除。额外的膜、酶辅因子或孵育时间均未改变产物形成量。发现唯一能刺激产物形成的因素是额外添加的肝脏脂肪酸结合蛋白。在没有ATP和辅酶A的情况下也显示出酰基辅酶A水解酶活性。这些研究表明,肝脏脂肪酸结合蛋白可通过结合该配体来增加酰基辅酶A的量,从而将其从膜中去除,并可能有助于其在细胞内的运输。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验